Literature DB >> 17853900

Growth of the Asian health-care market: global implications for the pharmaceutical industry.

Richard J Epstein1.   

Abstract

The global economy is being transformed by an explosion of information unleashed by the internet, the digital revolution, communications and increased international mobility. This transformation is manifesting in many ways, including rapid development of countries such as China, commoditization of public services, mobilization of workforces, shifting of market control from suppliers to consumers, interlinked rises in product demand and customer expectations, and problems regulating international business competition. As Asia is home to half of the world's population, and offers both a large relatively low-cost workforce in some countries and a potentially huge retail market, this region could be central to the future of the global economy. Like other industries, the pharmaceutical industry faces a new array of Asia-specific opportunities and challenges. Success in meeting these challenges will go to those pharmaceutical companies that best understand the unique strengths and constraints of Asia's diverse cultures, talents and markets.

Mesh:

Year:  2007        PMID: 17853900     DOI: 10.1038/nrd2360

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  4 in total

1.  Has discovery-based cancer research been a bust?

Authors:  R J Epstein
Journal:  Clin Transl Oncol       Date:  2013-09-04       Impact factor: 3.405

Review 2.  The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe.

Authors:  Richard J Epstein
Journal:  Front Oncol       Date:  2013-12-12       Impact factor: 6.244

3.  Unblocking blockbusters: using boolean text-mining to optimise clinical trial design and timeline for novel anticancer drugs.

Authors:  Richard J Epstein
Journal:  Cancer Inform       Date:  2009-08-17

4.  TRIPS-plus and access to medicines in China.

Authors:  Jing Chen; Xiaoyan Nie; Peng Yao; Luwen Shi
Journal:  J Public Health Policy       Date:  2013-04-04       Impact factor: 2.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.